

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.84257967 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.83665580 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.83665580 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.61427521 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.61427521 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 6.02247486 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.94499061 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61259026 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 5.45472574 |
| 10 | cysteine metabolic process (GO:0006534) | 5.38405784 |
| 11 | urea cycle (GO:0000050) | 5.36935824 |
| 12 | urea metabolic process (GO:0019627) | 5.36935824 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.32313758 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.29516668 |
| 15 | drug catabolic process (GO:0042737) | 5.24511424 |
| 16 | phospholipid efflux (GO:0033700) | 5.17857789 |
| 17 | negative regulation of cholesterol transport (GO:0032375) | 5.17559396 |
| 18 | negative regulation of sterol transport (GO:0032372) | 5.17559396 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 5.15258602 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 5.15258602 |
| 21 | tryptophan catabolic process (GO:0006569) | 5.15258602 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.13168606 |
| 23 | kynurenine metabolic process (GO:0070189) | 5.09423707 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 5.08036790 |
| 25 | reverse cholesterol transport (GO:0043691) | 4.97824989 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.96373198 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.91007186 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.89721927 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.89584376 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.87662273 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.87267032 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.77863713 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.77863713 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77863713 |
| 35 | intestinal absorption (GO:0050892) | 4.76606029 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.65384969 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.65384969 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 4.65384969 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 4.65384969 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 4.65384969 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.65384969 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64508602 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 4.63197771 |
| 44 | bile acid metabolic process (GO:0008206) | 4.60769167 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.60139623 |
| 46 | response to peptidoglycan (GO:0032494) | 4.59895249 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55750643 |
| 48 | lysine metabolic process (GO:0006553) | 4.51736300 |
| 49 | lysine catabolic process (GO:0006554) | 4.51736300 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 4.51600194 |
| 51 | flavonoid metabolic process (GO:0009812) | 4.48660142 |
| 52 | cholesterol efflux (GO:0033344) | 4.45730963 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43781408 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.43656395 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.43656395 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.42076840 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.40312062 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.40312062 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.39169899 |
| 60 | protein carboxylation (GO:0018214) | 4.39169899 |
| 61 | detection of other organism (GO:0098543) | 4.38837410 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 4.37336080 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.32342546 |
| 64 | regulation of fibrinolysis (GO:0051917) | 4.31179268 |
| 65 | regulation of bile acid biosynthetic process (GO:0070857) | 4.30336060 |
| 66 | detection of bacterium (GO:0016045) | 4.27475100 |
| 67 | cellular extravasation (GO:0045123) | 4.26332442 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 4.22524216 |
| 69 | negative regulation of cell killing (GO:0031342) | 4.19406799 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19406799 |
| 71 | glycine metabolic process (GO:0006544) | 4.16236092 |
| 72 | tyrosine metabolic process (GO:0006570) | 4.13175002 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.12694506 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.11807502 |
| 75 | cholesterol homeostasis (GO:0042632) | 4.09950707 |
| 76 | cellular glucuronidation (GO:0052695) | 4.08930089 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.08029829 |
| 78 | drug metabolic process (GO:0017144) | 4.07539374 |
| 79 | protein-lipid complex assembly (GO:0065005) | 4.07323440 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.05538300 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.04647518 |
| 82 | sterol homeostasis (GO:0055092) | 4.04191906 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 4.03863218 |
| 84 | exogenous drug catabolic process (GO:0042738) | 4.02806606 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98691274 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.95904267 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.92058852 |
| 88 | glutamate metabolic process (GO:0006536) | 3.90331039 |
| 89 | regulation of protein activation cascade (GO:2000257) | 3.85283544 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.81742463 |
| 91 | lipoprotein metabolic process (GO:0042157) | 3.81677141 |
| 92 | complement activation, alternative pathway (GO:0006957) | 3.79058561 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.78731839 |
| 94 | macrophage activation involved in immune response (GO:0002281) | 3.76431156 |
| 95 | neutrophil activation (GO:0042119) | 3.74735977 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.74419732 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.72953205 |
| 98 | ketone body metabolic process (GO:1902224) | 3.71591302 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.71471285 |
| 100 | arginine metabolic process (GO:0006525) | 3.70952415 |
| 101 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.67384076 |
| 102 | axonemal dynein complex assembly (GO:0070286) | 3.65427400 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.65018724 |
| 104 | coenzyme catabolic process (GO:0009109) | 3.63098748 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 3.62772577 |
| 106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62722892 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 3.60996539 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.60801830 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.60801830 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 3.60391613 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.60155746 |
| 112 | drug transmembrane transport (GO:0006855) | 3.60014084 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 3.58020445 |
| 114 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57474533 |
| 115 | organic acid catabolic process (GO:0016054) | 3.55786362 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.55786362 |
| 117 | detection of external biotic stimulus (GO:0098581) | 3.55386097 |
| 118 | ethanol oxidation (GO:0006069) | 3.54610663 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 3.53690034 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.50071579 |
| 121 | regulation of complement activation (GO:0030449) | 3.49667124 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 3.49210704 |
| 123 | cellular biogenic amine catabolic process (GO:0042402) | 3.46955782 |
| 124 | amine catabolic process (GO:0009310) | 3.46955782 |
| 125 | carnitine metabolic process (GO:0009437) | 3.46673155 |
| 126 | respiratory burst (GO:0045730) | 3.46386260 |
| 127 | imidazole-containing compound metabolic process (GO:0052803) | 3.42734948 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.41659620 |
| 129 | response to host (GO:0075136) | 3.41049373 |
| 130 | response to host defenses (GO:0052200) | 3.41049373 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.41049373 |
| 132 | cholesterol transport (GO:0030301) | 3.39641794 |
| 133 | sterol transport (GO:0015918) | 3.39641794 |
| 134 | granulocyte activation (GO:0036230) | 3.35787059 |
| 135 | response to host immune response (GO:0052572) | 3.34040161 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34040161 |
| 137 | tolerance induction (GO:0002507) | 3.33451573 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28575505 |
| 139 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24018681 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23500969 |
| 141 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.22996907 |
| 142 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.22996907 |
| 143 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21404336 |
| 144 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.21110537 |
| 145 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.14261883 |
| 146 | detection of molecule of bacterial origin (GO:0032490) | 3.11221234 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09190854 |
| 148 | detection of biotic stimulus (GO:0009595) | 3.02909887 |
| 149 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02886674 |
| 150 | negative regulation of interleukin-8 production (GO:0032717) | 2.97398242 |
| 151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96269624 |
| 152 | germinal center formation (GO:0002467) | 2.96131885 |
| 153 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94206734 |
| 154 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.93333424 |
| 155 | microglial cell activation (GO:0001774) | 2.92960165 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.92782613 |
| 157 | negative regulation of type 2 immune response (GO:0002829) | 2.91868570 |
| 158 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91509933 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90264774 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.89130584 |
| 161 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87702688 |
| 162 | macrophage activation (GO:0042116) | 2.86380689 |
| 163 | regulation of tolerance induction (GO:0002643) | 2.84731632 |
| 164 | negative regulation of interleukin-12 production (GO:0032695) | 2.84461087 |
| 165 | pentose-phosphate shunt (GO:0006098) | 2.84386947 |
| 166 | neutrophil mediated immunity (GO:0002446) | 2.84012212 |
| 167 | B cell mediated immunity (GO:0019724) | 2.83784568 |
| 168 | leukocyte aggregation (GO:0070486) | 2.82966556 |
| 169 | negative regulation of interleukin-6 production (GO:0032715) | 2.82105511 |
| 170 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81949586 |
| 171 | regulation of superoxide anion generation (GO:0032928) | 2.80910690 |
| 172 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77883100 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.77868403 |
| 174 | response to muramyl dipeptide (GO:0032495) | 2.75936729 |
| 175 | positive regulation of mast cell activation (GO:0033005) | 2.75779327 |
| 176 | embryonic process involved in female pregnancy (GO:0060136) | 2.74042919 |
| 177 | positive regulation of tolerance induction (GO:0002645) | 2.71810311 |
| 178 | regulation of mast cell activation (GO:0033003) | 2.69338116 |
| 179 | citrulline biosynthetic process (GO:0019240) | 2.67633624 |
| 180 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66221399 |
| 181 | primary alcohol catabolic process (GO:0034310) | 2.61612354 |
| 182 | negative regulation of phagocytosis (GO:0050765) | 2.61476271 |
| 183 | response to type I interferon (GO:0034340) | 2.61258629 |
| 184 | leukocyte degranulation (GO:0043299) | 2.61210579 |
| 185 | cellular response to type I interferon (GO:0071357) | 2.60645182 |
| 186 | type I interferon signaling pathway (GO:0060337) | 2.60645182 |
| 187 | phospholipid scrambling (GO:0017121) | 2.60340909 |
| 188 | motile cilium assembly (GO:0044458) | 2.58090580 |
| 189 | NADPH regeneration (GO:0006740) | 2.57149284 |
| 190 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.55529166 |
| 191 | pinocytosis (GO:0006907) | 2.54719529 |
| 192 | positive regulation of mast cell degranulation (GO:0043306) | 2.53975968 |
| 193 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53975968 |
| 194 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53058121 |
| 195 | lipoxygenase pathway (GO:0019372) | 2.51963522 |
| 196 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51410014 |
| 197 | positive regulation of leukocyte degranulation (GO:0043302) | 2.50672335 |
| 198 | negative regulation of T cell mediated immunity (GO:0002710) | 2.49992965 |
| 199 | desmosome organization (GO:0002934) | 2.49687380 |
| 200 | barbed-end actin filament capping (GO:0051016) | 2.48972108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.81277907 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.89348296 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14778134 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.92768130 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85299775 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65979989 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64829657 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.66569393 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50471117 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87359544 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.57380305 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54262237 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45311760 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42296185 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19837971 |
| 16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11100872 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.04645632 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00589578 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8313156 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98421719 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95963249 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95935988 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94955628 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92714427 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91640669 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.87368574 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84730830 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77741433 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76678309 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.74072833 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68612014 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66825663 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63094578 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59213278 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58757919 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54999441 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54952582 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.52465463 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51470014 |
| 40 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50741634 |
| 41 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49350750 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48391628 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46426249 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46113254 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45371652 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45046390 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40345651 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39767319 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39698496 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39186241 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37493063 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.35909446 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35133925 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35096233 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34895985 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33701481 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31943285 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29876447 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.29821343 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28962742 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.27253904 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26716165 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24914385 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23952616 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23826557 |
| 66 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23096541 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20028191 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19652431 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18457131 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18028971 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16289590 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15536789 |
| 73 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15483863 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15080486 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14017603 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13051510 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11201706 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09679402 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08941441 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08519619 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05656184 |
| 82 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.05378104 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04197545 |
| 84 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02908967 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02479353 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01665608 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01595042 |
| 88 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.01245926 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99352951 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93126674 |
| 91 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86938005 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84790132 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84540106 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83989385 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83973955 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83236646 |
| 97 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83018139 |
| 98 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78610614 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78586333 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78097274 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75830442 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75502280 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74479843 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74371327 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73910799 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73215400 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.73208395 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73076128 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72493667 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72126385 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70956076 |
| 112 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70888041 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67608616 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66998305 |
| 115 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.66357449 |
| 116 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.65746723 |
| 117 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65212712 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65073008 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64589222 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64556275 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.64137180 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64082218 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63738462 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63254142 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.63242709 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62961989 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62790496 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.62291076 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.62267243 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62248484 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62146052 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61875654 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.61284474 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60508755 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60157065 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59969668 |
| 137 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59585197 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59219387 |
| 139 | MAF_26560356_Chip-Seq_TH1_Human | 0.58857442 |
| 140 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58697034 |
| 141 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57441357 |
| 142 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57003077 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.56990170 |
| 144 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.56634268 |
| 145 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.55355744 |
| 146 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.55186246 |
| 147 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.54861544 |
| 148 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.53070745 |
| 149 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52942884 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52240797 |
| 151 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.51957624 |
| 152 | * MYB_26560356_Chip-Seq_TH1_Human | 0.51481746 |
| 153 | MYC_22102868_ChIP-Seq_BL_Human | 0.51189129 |
| 154 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50940669 |
| 155 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50553835 |
| 156 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.50334397 |
| 157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50191239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.92929811 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.37345941 |
| 3 | MP0005365_abnormal_bile_salt | 5.97366260 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.80742872 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10933445 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.02494378 |
| 7 | MP0009840_abnormal_foam_cell | 3.66867078 |
| 8 | MP0003252_abnormal_bile_duct | 3.56722764 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.38366403 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.35860120 |
| 11 | MP0005083_abnormal_biliary_tract | 2.98803764 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.65874404 |
| 13 | MP0005332_abnormal_amino_acid | 2.65414608 |
| 14 | MP0003303_peritoneal_inflammation | 2.60331208 |
| 15 | MP0002419_abnormal_innate_immunity | 2.55022688 |
| 16 | MP0009278_abnormal_bone_marrow | 2.41894609 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.30050426 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.25111723 |
| 19 | MP0008260_abnormal_autophagy | 2.19535226 |
| 20 | MP0000609_abnormal_liver_physiology | 2.11660703 |
| 21 | MP0003868_abnormal_feces_composition | 2.06037363 |
| 22 | MP0003195_calcinosis | 2.06034629 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 2.04345937 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.98991827 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.96933906 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.94726819 |
| 27 | MP0001790_abnormal_immune_system | 1.93985556 |
| 28 | MP0005387_immune_system_phenotype | 1.93985556 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.88710443 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.86039247 |
| 31 | MP0005451_abnormal_body_composition | 1.85631897 |
| 32 | MP0001800_abnormal_humoral_immune | 1.82497624 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.80655376 |
| 34 | MP0002723_abnormal_immune_serum | 1.80271041 |
| 35 | MP0001819_abnormal_immune_cell | 1.79856175 |
| 36 | MP0000858_altered_metastatic_potential | 1.75929238 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.73688837 |
| 38 | MP0003828_pulmonary_edema | 1.73298492 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.69513315 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.66072831 |
| 41 | MP0002405_respiratory_system_inflammati | 1.64956241 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.64604201 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.64479819 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.63829414 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.63829414 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.60535935 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.56019226 |
| 48 | MP0008004_abnormal_stomach_pH | 1.55717481 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.52005642 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.51796449 |
| 51 | MP0001764_abnormal_homeostasis | 1.51106996 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42830644 |
| 53 | MP0001851_eye_inflammation | 1.36641620 |
| 54 | MP0005671_abnormal_response_to | 1.35374958 |
| 55 | MP0005164_abnormal_response_to | 1.35152003 |
| 56 | MP0004883_abnormal_blood_vessel | 1.34241459 |
| 57 | MP0002398_abnormal_bone_marrow | 1.31693136 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.31346070 |
| 59 | MP0000716_abnormal_immune_system | 1.29923069 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.29640725 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.23592822 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.22885073 |
| 63 | MP0003075_altered_response_to | 1.17258544 |
| 64 | MP0009697_abnormal_copulation | 1.17250731 |
| 65 | MP0002429_abnormal_blood_cell | 1.14359655 |
| 66 | MP0002722_abnormal_immune_system | 1.13450166 |
| 67 | MP0005023_abnormal_wound_healing | 1.12508468 |
| 68 | MP0000598_abnormal_liver_morphology | 1.09181601 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.07674498 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.07268099 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 1.04975311 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.03720959 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 1.03592993 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.02829861 |
| 75 | MP0005390_skeleton_phenotype | 1.02485621 |
| 76 | MP0000490_abnormal_crypts_of | 1.01874871 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.01806898 |
| 78 | MP0002822_catalepsy | 1.01787769 |
| 79 | MP0005166_decreased_susceptibility_to | 1.00867740 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.00184314 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.99872013 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.96887085 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.95129805 |
| 84 | MP0003186_abnormal_redox_activity | 0.94079563 |
| 85 | MP0001853_heart_inflammation | 0.93875055 |
| 86 | MP0004381_abnormal_hair_follicle | 0.90595568 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.89966171 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.89474616 |
| 89 | MP0009764_decreased_sensitivity_to | 0.89450461 |
| 90 | MP0005310_abnormal_salivary_gland | 0.88666028 |
| 91 | MP0008469_abnormal_protein_level | 0.87969654 |
| 92 | MP0009642_abnormal_blood_homeostasis | 0.86755191 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.86322690 |
| 94 | MP0009763_increased_sensitivity_to | 0.85371911 |
| 95 | MP0000604_amyloidosis | 0.85268093 |
| 96 | MP0005448_abnormal_energy_balance | 0.83109540 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.82754384 |
| 98 | MP0004947_skin_inflammation | 0.82255159 |
| 99 | MP0001756_abnormal_urination | 0.80541429 |
| 100 | MP0000703_abnormal_thymus_morphology | 0.78210615 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.77387746 |
| 102 | MP0002254_reproductive_system_inflammat | 0.77235291 |
| 103 | MP0003448_altered_tumor_morphology | 0.76986317 |
| 104 | MP0002132_abnormal_respiratory_system | 0.76667882 |
| 105 | MP0003091_abnormal_cell_migration | 0.76665934 |
| 106 | MP0003878_abnormal_ear_physiology | 0.75744016 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.75744016 |
| 108 | MP0005165_increased_susceptibility_to | 0.75511925 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.75262474 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.74761876 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.74535814 |
| 112 | MP0005408_hypopigmentation | 0.74530046 |
| 113 | MP0003763_abnormal_thymus_physiology | 0.72917237 |
| 114 | MP0005501_abnormal_skin_physiology | 0.72856429 |
| 115 | MP0002971_abnormal_brown_adipose | 0.72309764 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.72179338 |
| 117 | MP0003795_abnormal_bone_structure | 0.71144397 |
| 118 | MP0005334_abnormal_fat_pad | 0.69539992 |
| 119 | MP0001958_emphysema | 0.69183168 |
| 120 | MP0003011_delayed_dark_adaptation | 0.65843900 |
| 121 | MP0003866_abnormal_defecation | 0.64773719 |
| 122 | MP0005647_abnormal_sex_gland | 0.64519718 |
| 123 | MP0001873_stomach_inflammation | 0.63254078 |
| 124 | MP0002166_altered_tumor_susceptibility | 0.62597002 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.61983408 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.61493095 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.60982621 |
| 128 | MP0004043_abnormal_pH_regulation | 0.60382089 |
| 129 | MP0001663_abnormal_digestive_system | 0.59787541 |
| 130 | MP0004130_abnormal_muscle_cell | 0.58471133 |
| 131 | MP0006082_CNS_inflammation | 0.57528086 |
| 132 | MP0000462_abnormal_digestive_system | 0.57304841 |
| 133 | MP0005670_abnormal_white_adipose | 0.56632619 |
| 134 | MP0008872_abnormal_physiological_respon | 0.55575038 |
| 135 | MP0005535_abnormal_body_temperature | 0.53878497 |
| 136 | MP0005266_abnormal_metabolism | 0.52878505 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.51979617 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.51922662 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.50247250 |
| 140 | MP0008873_increased_physiological_sensi | 0.50200369 |
| 141 | MP0003718_maternal_effect | 0.50062626 |
| 142 | MP0002796_impaired_skin_barrier | 0.49833511 |
| 143 | MP0001661_extended_life_span | 0.49287502 |
| 144 | MP0001243_abnormal_dermal_layer | 0.48301549 |
| 145 | MP0000685_abnormal_immune_system | 0.48123222 |
| 146 | MP0003436_decreased_susceptibility_to | 0.47917324 |
| 147 | MP0001849_ear_inflammation | 0.47875770 |
| 148 | MP0000477_abnormal_intestine_morphology | 0.46818569 |
| 149 | MP0009115_abnormal_fat_cell | 0.45240832 |
| 150 | MP0003724_increased_susceptibility_to | 0.44242492 |
| 151 | MP0009785_altered_susceptibility_to | 0.43131316 |
| 152 | MP0003953_abnormal_hormone_level | 0.42866173 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.41143056 |
| 154 | MP0009053_abnormal_anal_canal | 0.40712275 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.39889277 |
| 156 | MP0008961_abnormal_basal_metabolism | 0.38800951 |
| 157 | MP0003329_amyloid_beta_deposits | 0.37878157 |
| 158 | MP0005395_other_phenotype | 0.37128224 |
| 159 | MP0008874_decreased_physiological_sensi | 0.36377794 |
| 160 | MP0000249_abnormal_blood_vessel | 0.35741974 |
| 161 | MP0005025_abnormal_response_to | 0.35313781 |
| 162 | MP0002970_abnormal_white_adipose | 0.35191174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.76455336 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.62216435 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.14439283 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.13920557 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.93762573 |
| 6 | Xanthomatosis (HP:0000991) | 5.71998585 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.44167119 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.13868723 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.02066879 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.94828728 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.90802104 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.76916050 |
| 13 | Myositis (HP:0100614) | 4.72274690 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.55514507 |
| 15 | Hyperammonemia (HP:0001987) | 4.49310743 |
| 16 | Hyperglycinuria (HP:0003108) | 4.46165756 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.35860950 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30609814 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26994255 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26212919 |
| 21 | Fat malabsorption (HP:0002630) | 4.21547626 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17924058 |
| 23 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.16550856 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.11346945 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.11346945 |
| 26 | Ketosis (HP:0001946) | 4.03677598 |
| 27 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.97919291 |
| 28 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.97919291 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.96010739 |
| 30 | Hyperglycinemia (HP:0002154) | 3.93766374 |
| 31 | Absent/shortened dynein arms (HP:0200106) | 3.90750282 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.90750282 |
| 33 | Epidermoid cyst (HP:0200040) | 3.90461544 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77828583 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.75832593 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.75471512 |
| 37 | Joint hemorrhage (HP:0005261) | 3.74989493 |
| 38 | Nasal polyposis (HP:0100582) | 3.71702748 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64118699 |
| 40 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.58684459 |
| 41 | Orchitis (HP:0100796) | 3.55570853 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55327020 |
| 43 | Abnormal ciliary motility (HP:0012262) | 3.53630107 |
| 44 | Hypoglycemic coma (HP:0001325) | 3.53547890 |
| 45 | Hypercholesterolemia (HP:0003124) | 3.53473790 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 3.36489453 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32742997 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26605017 |
| 49 | Chronic bronchitis (HP:0004469) | 3.22326352 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.21810143 |
| 51 | Complement deficiency (HP:0004431) | 3.18513055 |
| 52 | Rhinitis (HP:0012384) | 3.16523710 |
| 53 | Malnutrition (HP:0004395) | 3.15237680 |
| 54 | Acanthocytosis (HP:0001927) | 3.14800333 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13373809 |
| 56 | Prolonged bleeding time (HP:0003010) | 3.13311285 |
| 57 | Petechiae (HP:0000967) | 3.11612646 |
| 58 | Hyperbilirubinemia (HP:0002904) | 3.11171462 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 3.10692242 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 3.05051705 |
| 61 | Ketoacidosis (HP:0001993) | 3.04512493 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01147898 |
| 63 | Obstructive lung disease (HP:0006536) | 3.01147898 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 3.00949726 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.97068498 |
| 66 | Bronchiectasis (HP:0002110) | 2.94387671 |
| 67 | Metabolic acidosis (HP:0001942) | 2.92212574 |
| 68 | Steatorrhea (HP:0002570) | 2.89861944 |
| 69 | Gout (HP:0001997) | 2.87518006 |
| 70 | Optic neuritis (HP:0100653) | 2.84671468 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.84671468 |
| 72 | Cellulitis (HP:0100658) | 2.84440991 |
| 73 | Gingivitis (HP:0000230) | 2.83854973 |
| 74 | Increased IgE level (HP:0003212) | 2.83721558 |
| 75 | T lymphocytopenia (HP:0005403) | 2.80669566 |
| 76 | Pustule (HP:0200039) | 2.80168090 |
| 77 | Recurrent skin infections (HP:0001581) | 2.77143076 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.75553858 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.75553858 |
| 80 | Stomatitis (HP:0010280) | 2.73090964 |
| 81 | Epistaxis (HP:0000421) | 2.69482117 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 2.69290115 |
| 83 | Delayed CNS myelination (HP:0002188) | 2.68418219 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.68097669 |
| 85 | Recurrent sinusitis (HP:0011108) | 2.67296139 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.66691750 |
| 87 | Combined immunodeficiency (HP:0005387) | 2.64482104 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.64100577 |
| 89 | Urticaria (HP:0001025) | 2.63997014 |
| 90 | Ileus (HP:0002595) | 2.62231411 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61803007 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.61803007 |
| 93 | Purpura (HP:0000979) | 2.61322003 |
| 94 | Increased cerebral lipofuscin (HP:0011813) | 2.61026578 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.58589474 |
| 96 | Myocardial infarction (HP:0001658) | 2.54703096 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 2.54553392 |
| 98 | Meningitis (HP:0001287) | 2.54459552 |
| 99 | Vascular calcification (HP:0004934) | 2.54303992 |
| 100 | Lethargy (HP:0001254) | 2.52376852 |
| 101 | Loss of speech (HP:0002371) | 2.52362221 |
| 102 | Chronic otitis media (HP:0000389) | 2.50168541 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.50070671 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.41483551 |
| 105 | Thrombocytosis (HP:0001894) | 2.39828574 |
| 106 | B lymphocytopenia (HP:0010976) | 2.39083667 |
| 107 | Abnormality of B cell number (HP:0010975) | 2.39083667 |
| 108 | Alkalosis (HP:0001948) | 2.38430399 |
| 109 | Spontaneous abortion (HP:0005268) | 2.37269833 |
| 110 | Increased serum ferritin (HP:0003281) | 2.37051753 |
| 111 | Episodic fever (HP:0001954) | 2.36367676 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34447951 |
| 113 | Spastic diplegia (HP:0001264) | 2.32904448 |
| 114 | Poikilocytosis (HP:0004447) | 2.31677621 |
| 115 | Pancreatitis (HP:0001733) | 2.29330298 |
| 116 | Polygenic inheritance (HP:0010982) | 2.28592422 |
| 117 | Esophageal varix (HP:0002040) | 2.28532747 |
| 118 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28375524 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.27861044 |
| 120 | Irritability (HP:0000737) | 2.27803642 |
| 121 | Abnormality of complement system (HP:0005339) | 2.26774927 |
| 122 | Late onset (HP:0003584) | 2.26479621 |
| 123 | Anorexia (HP:0002039) | 2.23856961 |
| 124 | Chest pain (HP:0100749) | 2.23144800 |
| 125 | Cardiovascular calcification (HP:0011915) | 2.21518155 |
| 126 | Hypoglycemic seizures (HP:0002173) | 2.21182813 |
| 127 | Skin nodule (HP:0200036) | 2.20879695 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 2.18152626 |
| 129 | Vasculitis (HP:0002633) | 2.18012893 |
| 130 | Inflammation of the large intestine (HP:0002037) | 2.17737754 |
| 131 | Peritonitis (HP:0002586) | 2.13896968 |
| 132 | Premature loss of primary teeth (HP:0006323) | 2.13531097 |
| 133 | Abnormal cartilage morphology (HP:0002763) | 2.12490233 |
| 134 | Hypergammaglobulinemia (HP:0010702) | 2.12193695 |
| 135 | Arterial thrombosis (HP:0004420) | 2.10951063 |
| 136 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10191129 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 2.08869253 |
| 138 | Glycosuria (HP:0003076) | 2.07652459 |
| 139 | Abnormality of urine glucose concentration (HP:0011016) | 2.07652459 |
| 140 | Recurrent otitis media (HP:0000403) | 2.06735112 |
| 141 | Easy fatigability (HP:0003388) | 2.06386068 |
| 142 | Male infertility (HP:0003251) | 2.06090675 |
| 143 | Bronchitis (HP:0012387) | 2.05801977 |
| 144 | Vomiting (HP:0002013) | 2.04326154 |
| 145 | Glomerulonephritis (HP:0000099) | 2.04110745 |
| 146 | Autoimmune thrombocytopenia (HP:0001973) | 2.03565958 |
| 147 | Generalized aminoaciduria (HP:0002909) | 2.03103140 |
| 148 | Hyperuricemia (HP:0002149) | 2.02819465 |
| 149 | Increased purine levels (HP:0004368) | 2.02819465 |
| 150 | Granulocytopenia (HP:0001913) | 2.02317408 |
| 151 | Proximal tubulopathy (HP:0000114) | 2.00484750 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.99418329 |
| 153 | Cerebral edema (HP:0002181) | 1.98958372 |
| 154 | Hypochromic microcytic anemia (HP:0004840) | 1.98954139 |
| 155 | Osteomyelitis (HP:0002754) | 1.98859280 |
| 156 | Abnormal tarsal ossification (HP:0008369) | 1.97031756 |
| 157 | Hemoptysis (HP:0002105) | 1.96346699 |
| 158 | Flat acetabular roof (HP:0003180) | 1.95909959 |
| 159 | Menorrhagia (HP:0000132) | 1.95323631 |
| 160 | Keratoconjunctivitis sicca (HP:0001097) | 1.95161455 |
| 161 | Brushfield spots (HP:0001088) | 1.94291744 |
| 162 | Acute hepatic failure (HP:0006554) | 1.94150457 |
| 163 | Chronic sinusitis (HP:0011109) | 1.93236658 |
| 164 | Amyloidosis (HP:0011034) | 1.92606507 |
| 165 | Abnormal platelet volume (HP:0011876) | 1.91811503 |
| 166 | Encephalitis (HP:0002383) | 1.91635318 |
| 167 | Abnormality of vitamin metabolism (HP:0100508) | 1.91585386 |
| 168 | Colitis (HP:0002583) | 1.90810517 |
| 169 | Gingival bleeding (HP:0000225) | 1.90654675 |
| 170 | Hypertensive crisis (HP:0100735) | 1.90494655 |
| 171 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90333704 |
| 172 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90333704 |
| 173 | Abnormal gallbladder morphology (HP:0012437) | 1.89923294 |
| 174 | Increased mean platelet volume (HP:0011877) | 1.89415117 |
| 175 | Thyroiditis (HP:0100646) | 1.88638263 |
| 176 | Cholelithiasis (HP:0001081) | 1.87012323 |
| 177 | Pulmonary infiltrates (HP:0002113) | 1.86876357 |
| 178 | Skin ulcer (HP:0200042) | 1.86528384 |
| 179 | Increased connective tissue (HP:0009025) | 1.86463216 |
| 180 | Growth hormone excess (HP:0000845) | 1.85811193 |
| 181 | Eosinophilia (HP:0001880) | 1.82469595 |
| 182 | Hemorrhage of the eye (HP:0011885) | 1.82051359 |
| 183 | Neonatal onset (HP:0003623) | 1.82018613 |
| 184 | Sensorimotor neuropathy (HP:0007141) | 1.81076832 |
| 185 | Dysostosis multiplex (HP:0000943) | 1.80969980 |
| 186 | Nephrolithiasis (HP:0000787) | 1.80644783 |
| 187 | Pulmonary embolism (HP:0002204) | 1.78771362 |
| 188 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77538474 |
| 189 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77538474 |
| 190 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77538474 |
| 191 | Widely patent fontanelles and sutures (HP:0004492) | 1.77485110 |
| 192 | Abnormal vertebral ossification (HP:0100569) | 1.75545027 |
| 193 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75443669 |
| 194 | Slow saccadic eye movements (HP:0000514) | 1.73996572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.84208498 |
| 2 | FGFR4 | 3.95754099 |
| 3 | ERN1 | 3.61880078 |
| 4 | PKN2 | 3.43826519 |
| 5 | GRK6 | 3.27388043 |
| 6 | RIPK4 | 3.12201283 |
| 7 | MST1R | 3.08398534 |
| 8 | SIK1 | 3.00749467 |
| 9 | FRK | 2.90517344 |
| 10 | IRAK4 | 2.54260408 |
| 11 | TXK | 2.53617124 |
| 12 | MAP4K1 | 2.32367140 |
| 13 | MAP3K10 | 2.08271464 |
| 14 | PTK6 | 2.05229276 |
| 15 | TYK2 | 2.00037263 |
| 16 | MST4 | 1.98266921 |
| 17 | TAOK3 | 1.95680828 |
| 18 | TRIB3 | 1.91187734 |
| 19 | ZAP70 | 1.86331092 |
| 20 | FLT3 | 1.83139322 |
| 21 | IRAK3 | 1.81911495 |
| 22 | BLK | 1.78864873 |
| 23 | PRPF4B | 1.74179611 |
| 24 | INSRR | 1.72955948 |
| 25 | SMG1 | 1.72221115 |
| 26 | MAPK15 | 1.67672045 |
| 27 | MAP3K7 | 1.64076720 |
| 28 | TNK2 | 1.54454110 |
| 29 | FGR | 1.53199314 |
| 30 | STK10 | 1.45605304 |
| 31 | MAPK11 | 1.41944493 |
| 32 | SIK3 | 1.41831292 |
| 33 | ITK | 1.40951220 |
| 34 | MAP2K2 | 1.36587081 |
| 35 | CSK | 1.36297330 |
| 36 | PAK4 | 1.33294974 |
| 37 | BTK | 1.29321043 |
| 38 | FES | 1.18317472 |
| 39 | CSF1R | 1.17657491 |
| 40 | BMX | 1.12664806 |
| 41 | IRAK2 | 1.09811470 |
| 42 | NLK | 1.08995330 |
| 43 | PRKD2 | 1.07400957 |
| 44 | EPHB1 | 1.03841689 |
| 45 | PIK3CG | 1.02787498 |
| 46 | JAK2 | 1.00969580 |
| 47 | KDR | 1.00913338 |
| 48 | MATK | 1.00836988 |
| 49 | MARK2 | 1.00789445 |
| 50 | TBK1 | 1.00435809 |
| 51 | MAP2K4 | 0.99620860 |
| 52 | MAPK4 | 0.99317655 |
| 53 | KIT | 0.98377830 |
| 54 | MAPK7 | 0.97413419 |
| 55 | IRAK1 | 0.96291734 |
| 56 | FGFR2 | 0.93267303 |
| 57 | PRKAA2 | 0.92773829 |
| 58 | FGFR3 | 0.91804143 |
| 59 | ICK | 0.87717747 |
| 60 | MAPK12 | 0.85164723 |
| 61 | RIPK1 | 0.83762351 |
| 62 | ERBB4 | 0.83654946 |
| 63 | IKBKE | 0.83274821 |
| 64 | LMTK2 | 0.80948769 |
| 65 | CDK6 | 0.79209841 |
| 66 | PRKCQ | 0.78399109 |
| 67 | MAP2K6 | 0.78254706 |
| 68 | PTK2B | 0.78027576 |
| 69 | JAK1 | 0.76992735 |
| 70 | CDC42BPA | 0.76985221 |
| 71 | TESK1 | 0.76164489 |
| 72 | PRKG2 | 0.76032291 |
| 73 | PDGFRB | 0.74415346 |
| 74 | TAOK2 | 0.72887985 |
| 75 | DYRK1B | 0.72700741 |
| 76 | LYN | 0.71250691 |
| 77 | LRRK2 | 0.70225086 |
| 78 | LATS1 | 0.68763599 |
| 79 | MAP3K6 | 0.67853954 |
| 80 | MAP3K11 | 0.67619091 |
| 81 | MAP2K3 | 0.67482819 |
| 82 | EEF2K | 0.65978232 |
| 83 | MET | 0.64908345 |
| 84 | MAP3K3 | 0.63659621 |
| 85 | NME1 | 0.62850210 |
| 86 | NUAK1 | 0.62806954 |
| 87 | STK38 | 0.61043274 |
| 88 | ERBB2 | 0.60878363 |
| 89 | SGK3 | 0.60399367 |
| 90 | MAPKAPK2 | 0.60389677 |
| 91 | MAP3K13 | 0.58659293 |
| 92 | PDK1 | 0.57245690 |
| 93 | TTN | 0.57108185 |
| 94 | PIK3CA | 0.56264151 |
| 95 | SYK | 0.56133266 |
| 96 | MAP3K8 | 0.54942184 |
| 97 | CDK4 | 0.54020926 |
| 98 | TESK2 | 0.53668831 |
| 99 | LCK | 0.52533031 |
| 100 | CDK9 | 0.52482132 |
| 101 | MAP3K14 | 0.52298102 |
| 102 | HIPK2 | 0.52296515 |
| 103 | PTK2 | 0.52186429 |
| 104 | PRKAA1 | 0.50750788 |
| 105 | CDK12 | 0.50442710 |
| 106 | IKBKB | 0.48553243 |
| 107 | PDK4 | 0.48355668 |
| 108 | PDK3 | 0.48355668 |
| 109 | PDPK1 | 0.47056627 |
| 110 | NME2 | 0.46992023 |
| 111 | TAOK1 | 0.46695947 |
| 112 | KSR2 | 0.46565263 |
| 113 | CSNK1G1 | 0.46560113 |
| 114 | MAP3K1 | 0.44084212 |
| 115 | PRKCD | 0.42541935 |
| 116 | PRKACG | 0.42433838 |
| 117 | FYN | 0.41805200 |
| 118 | RET | 0.41419194 |
| 119 | NEK9 | 0.41323062 |
| 120 | PRKCZ | 0.40721794 |
| 121 | PRKCI | 0.40335442 |
| 122 | AKT3 | 0.39701148 |
| 123 | TGFBR2 | 0.39402268 |
| 124 | EPHA2 | 0.39199990 |
| 125 | ACVR1B | 0.38937113 |
| 126 | RPS6KL1 | 0.38925095 |
| 127 | RPS6KC1 | 0.38925095 |
| 128 | DAPK2 | 0.37290782 |
| 129 | YES1 | 0.37278895 |
| 130 | MAP2K1 | 0.37125055 |
| 131 | RPS6KA2 | 0.36308269 |
| 132 | MAP3K2 | 0.36147853 |
| 133 | ABL2 | 0.36022301 |
| 134 | TEC | 0.35858866 |
| 135 | MAPKAPK3 | 0.35352125 |
| 136 | JAK3 | 0.35069083 |
| 137 | GRK1 | 0.33621778 |
| 138 | CAMK1D | 0.32758958 |
| 139 | RPS6KB2 | 0.32699139 |
| 140 | MTOR | 0.32473779 |
| 141 | CSNK1A1L | 0.32017000 |
| 142 | MELK | 0.31784798 |
| 143 | PRKD1 | 0.31426791 |
| 144 | CSNK1G3 | 0.31087493 |
| 145 | STK24 | 0.30627232 |
| 146 | HCK | 0.29973079 |
| 147 | IGF1R | 0.29799963 |
| 148 | GSK3A | 0.29111396 |
| 149 | STK4 | 0.28635653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.65097334 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.60559028 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.22346244 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.97648679 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92034519 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89936099 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59852683 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54043154 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49306114 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48291431 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46050296 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40549585 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40113205 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39956245 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.34725375 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34198734 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14054700 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08661195 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03084514 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00935146 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00749313 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90374222 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89444020 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87690741 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85837988 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85501319 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.85200090 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.84469282 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83521729 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.80417836 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79781810 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77348051 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.73853464 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.72431220 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72035321 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71342440 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70996516 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69237231 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68792650 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63618316 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62028593 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.58923008 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58856331 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58682370 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54691762 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53948953 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51954641 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51098932 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51055291 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47334461 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45042232 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44084759 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40694135 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38415662 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38264887 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.37051630 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35619330 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 1.34413990 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33978312 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 1.31905260 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31667604 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 1.27302355 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.27203076 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26779775 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22160420 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21941387 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21240071 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20996929 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19841203 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19071616 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 1.18311854 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16091994 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15677006 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15552730 |
| 75 | Measles_Homo sapiens_hsa05162 | 1.15450767 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14730235 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14680624 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14657613 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 1.14625212 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12659579 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10576524 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10333392 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08132609 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07910461 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07004749 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06158406 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05779718 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04662347 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03267373 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02912994 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02859867 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 1.02846800 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02750258 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02614142 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 1.01072700 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.98019893 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96645528 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.95418531 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94162151 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93924820 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.92958659 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.90740274 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.89982659 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86878164 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86071741 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85515896 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81065410 |
| 108 | Hepatitis B_Homo sapiens_hsa05161 | 0.79994480 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.79979487 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79509098 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78592223 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78206357 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76345692 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74887191 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72735208 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72225521 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71395889 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70826126 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70281442 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70197725 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68731140 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66937684 |
| 123 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65191669 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62677863 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61705556 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60693609 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60433176 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60051089 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58890912 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58722993 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58685507 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57940502 |
| 133 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54562307 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54196557 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53522389 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52943708 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51667749 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50602083 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50542514 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.49861593 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.49202402 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45066583 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39668495 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35441462 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34146213 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32336587 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30823379 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29153323 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.25315756 |
| 150 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21064447 |
| 151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13673652 |
| 152 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13285800 |
| 153 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.08502227 |
| 154 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00731072 |
| 155 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.2122689 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | -0.2034151 |
| 157 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2011638 |
| 158 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1920802 |
| 159 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1578661 |
| 160 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1289503 |
| 161 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1113443 |
| 162 | Hepatitis C_Homo sapiens_hsa05160 | -0.0912725 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0911055 |
| 164 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0756970 |
| 165 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0565768 |
| 166 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0519922 |
| 167 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0406663 |
| 168 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0308062 |
| 169 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0224051 |
| 170 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | -0.0065900 |

